Dr. Gerhard C. Hildebrandt

Dr. Gerhard C. Hildebrandt |Clyto Access

Division Chief, University of Kentucky, USA

Co - Editor-in-Chief

Expertise: Stem cell transplantation, Chronic graft versus host disease

Dr. Hildebrandt received his medical degree from the Johannes Gutenberg University of Mainz Medical School, Germany, in 1997. On completion of doctoral research thesis, he was awarded the "doctor medicine" with magna cum laude. Dr. Hildebrandt completed a residency in Internal Medicine and a Hematology and Oncology fellowship at the University of Regensburg, Germany and became Bone Marrow Transplant and Hematologic Malignancies Attending at the University of Regensburg. In 2009 he was awarded the "Habilitation", the highest academic qualification a scholar can achieve by own pursuit in Germany. After moving to the United States in 2009, Dr. Hildebrandt was a faculty member at the Louisiana State University in Shreveport, and at the University of Utah. He was the director of the bone marrow transplant program at LSUHSC Shreveport and director of the Utah Blood and Marrow Transplant program at the Huntsman Cancer Institute/University of Utah, before moving to his current assignment in 2015. Dr. Hildebrandt’s focus is patients with cancers of the blood and lymph system, patients before and after blood or marrow stem cell transplantation and on patients suffering from acute and chronic graft versus host disease. Currently, he is a Division Chief of Hematology and Blood and Marrow Transplantation in University of Kentucky, Markey Cancer Center, Kentucky, United States.

Related Journals & Conferences :

Global Forum on Transplantation Research and Technologies

International Journal of Transplantation Research and Technology